Shopping Cart
Remove All
Your shopping cart is currently empty
TL1A/TNFSF15 Protein, Human, Recombinant (monomeric hFc) is expressed in HEK293 Cells. The accession number is O95150-1.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 μg | $44 | 7-10 days | 7-10 days | |
| 10 μg | $68 | 7-10 days | 7-10 days | |
| 20 μg | $108 | 7-10 days | 7-10 days | |
| 50 μg | $198 | 7-10 days | 7-10 days | |
| 100 μg | $346 | 7-10 days | 7-10 days | |
| 200 μg | $613 | 7-10 days | 7-10 days | |
| 500 μg | Preferential | 7-10 days | 7-10 days |
| Biological Activity | Immobilized Human TNFSF15, hFc Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-TNFSF15 Antibody, hFc Tag with the EC50 of 15.5 ng/ml determined by ELISA. |
| Description | TL1A/TNFSF15 Protein, Human, Recombinant (monomeric hFc) is expressed in HEK293 Cells. The accession number is O95150-1. |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | N-monomeric Fc |
| Accession Number | O95150-1 |
| Synonyms | VEGI192A,VEGI,tumor necrosis factor (ligand) superfamily, member 15,TL1A,TL1 |
| Construction | Leu72-Leu251 |
| Protein Purity | > 95% as determined by Tris-Bis PAGE; > 90% as determined by HPLC |
| Molecular Weight | 44.87 kDa (Predicted); 48-60 kDa (Due to glycosylation) |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). |
| Stability & Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Shipping | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
| Research Background | TNF superfamily member 15 (TNFSF15), a cytokine largely produced by vascular endothelial cells and a specific inhibitor of the proliferation of these same cells, can inhibit VEGF-induced vascular permeability in vitro and in vivo, and that death receptor 3 (DR3), a cell surface receptor of TNFSF15, mediates TNFSF15-induced dephosphorylation of VEGFR2. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.